Freakonomics Radio cover image

269. Bad Medicine, Part 2: (Drug) Trials and Tribulations

Freakonomics Radio

00:00

The Tuskegee Dilemma

A recent study by two economists found that the tuskegee revelation seriously diminished african americans participation in the health care system. They were simply less willing to go to a doctor or a hospital. With such a fraught history of inclusion andex sion in medical studies, who does end up in clinical trials? Also, how good are the new drugs that typically make it to market? I think if we're honest with ourselves, we'll have to admit that the majority of new cancer drugs offer sort of very small gains at tremendous prices.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app